Ortho's VITROS ®  HIV Combo Test was recently featured in Kalorama Information's report, "The Latest Developments in HIV Diagnostic Testing." Read more .   Press contact: For media inquiries please contact Ortho Media Relations Ortho Clinical Diagnostics media@orthoclinicaldiagnostics.com (+1) 908

New Availability of the VITROS ®  Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator to Help Labs Using Ortho's VITROS ®  ECi/ECiQ Immunodiagnostic System to Diagnose HIV Infection Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that its VITROS ®

Expanded use on the VITROS ®  5600 Integrated System will help labs maximize workflow efficiencies Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that the VITROS ®  Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator (VITROS ®  HIV Combo test) received

DIGITAL CHEMISTRY™ technology enables powerful data intelligence, operational improvements and other enhancements in the lab Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that it has received FDA clearance for Ortho's  VITROS ®  XT 7600 Integrated System.

Becker’s Hospital Review featured an article by Ortho's Jay Snyder on how to measure the immense value clinical labs drive throughout the health care system. Read the article.   Press contact: For media inquiries please contact Ortho Media Relations Ortho Clinical Diagnostics

Customer event to highlight how access to information and advances in automation can improve transfusion medicine operations Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced it will highlight how connectivity can improve operational excellence in

Kappa Free Light Chain and Lambda Free Light Chain MPAs cleared for use in diagnosing and monitoring plasma cell disorders, neoplastic diseases; Methotrexate MPA cleared for use in monitoring therapeutic levels of methotrexate Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, is

Assay is now available in Mexico and countries that accept CE mark Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced the introduction of its next-generation Anti-T. cruzi assay, with CE Mark approval and approval for use in Mexico.

Company achieves ranking based on positive employee experience and high-quality people practices Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, has been named one of India's Great Mid-Size Workplaces 2018 by Great Place to Work ®  Institute, an institute focused on

Recognized as one of the most influential companies in the Medical Device/Diagnostic category Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, has been named The Trailblazer 2018 Company of the Year in the Medical Device/Diagnostics category by PM360, a respected